Ten-year remission of psoriasis after allogeneic but not autologous bone marrow transplantation [4]

Dermatology

Volumn 212, Issue 1, 2005, Pages 88-89

  Masszi, Tamas ^a   Farkas, Arpad ^b   Remenyi, Peter ^a   Lueff, Sandor ^a   Batai, Arpad ^a   Krivan, Gergely ^a   Kemeny, Lajos ^b   Dobozy, Attila ^b   Reti, Marienn ^a  

^a Szent Laszlo Hospital   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Allogeneic bone marrow transplantation; Autologous bone marrow transplantation; Immune mediated diseases; Psoriasis

Indexed keywords

ANTIPSORIASIS AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; PREDNISONE; THYMOCYTE ANTIBODY; VINCRISTINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLEEDING; BONE GRAFT; CASE REPORT; CELL NUCLEUS; CHROMOSOME ANALYSIS; FEVER; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; MITOSIS; NEUTROPHIL; NONHODGKIN LYMPHOMA; PANCYTOPENIA; PRIORITY JOURNAL; PROPHYLAXIS; PSORIASIS; REMISSION; SKIN DEFECT; STEM CELL;

ADULT; BONE MARROW TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PSORIASIS; REMISSION INDUCTION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 28844487006     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089032     Document Type: Letter

References (10)

1. Nickoloff BJ, Nestle FO: Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004;113:1664-1675.
2. Sullivan KM: Bone marrow transplantation for non-malignant disease. Int J Hematol 2002;76(Suppl 1):169-170.
3. Kanamori H, Tanaka M, Kawaguchi H, Yamaji S, Fujimaki K, Tomita N, Fujisawa S, Ishigatsubo Y: Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: Case report and review of the literature. Am J Hematol 2002;71:41-44.
4. Snowden JA, Kearney P, Kearney A, Cooley HM, Grigg A, Jacobs P, Bergman J, Brooks PM, Biggs JC: Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 1998;41:453-459.
5. Eedy DJ, Burrows D, Bridges JM, Jones FG: Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ 1990;300:908.
6. Cooley HM, Snowden JA, Grigg AP, Wicks IP: Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy. Arthritis Rheum 1997;40:1712-1715.
7. Snowden JA, Heaton DC: Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: Further evidence for adoptive autoimmunity. Br J Dermatol 1997;137:130-132.
8. Daikeler T, Gunaydin I, Einsele H, Kanz L, Kotter I: Transmission of psoriatic arthritis by allogeneic bone marrow transplantation for chronic myelogenous leukaemia from an HLA-identical donor. Rheumatology (Oxford) 1999;38:89-90.
9. Lopez-Cubero SO, Sullivan KM, McDonald GB: Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology 1998;114:433-440.
10. Hinterberger W, Hinterberger-Fischer M, Marmont A: Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002;30:753-759.